Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics
Key facts
- Where
- Salt Lake City, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 17 years old?
Source: NCT06825520, who can take part
Where in United States
- University of UtahSalt Lake City, United StatesContact: Emily I Braley, MSTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Utah
- Trial code
- NCT06825520
- Record updated
- 28 May 2025
- Original description
The primary aim of this study is to learn more about premonitory urges (PU) when using Habit Reversal Training (HRT) to treat tics.Read full original descriptionShow less
Investigating Changes in Premonitory Urges During Habit Reversal Training
The primary aim of this study is to learn more about premonitory urges (PU) when using Habit Reversal Training (HRT) to treat tics.
The main focus of this study is to investigate if and when PU change during tic treatment sessions and between tic treatment sessions.
Participants will:
* Attend 5 study visits (approximately 1 to 1.5 hours each) for an intake, habit reversal training for 3 separate tics, and a post assessment * Attend 5 practice sessions (approximately 30 minutes each) over a week for 3 weeks (total 15 practice sessions) * Study visits and practice sessions will take place in person and online via secure videoconference
Inclusion: Participants who meet criteria for a DSM-5-TR diagnosis of a TD will be recruited to participate in this study. Participants will be eligible for the study if they; present with at least three motor and/or vocal tics and are interested in receiving treatment,; report experiencing a PU for each of their target tics with a minimum rating of a 4/8 on a subjective rating (i.e., the Urge Thermometer; Silverman \& Albano, 1996) for each tic,; the targeted tics occur, on average, at least once per minute during a 10-minute direct observation,; are between the ages of 8 and 17; the patient has no planned changes in medication initiation or dosage during their study participation period.
Exclusion: have previously engaged in CBIT or HRT for more than 2 sessions,; the presence of any comorbid conditions that are considered a primary treatment concern and/or could interfere with study participation or treatment (i.e., unmanaged ADHD, OCD, anxiety),; a Yale Global Tic Severity Score of 40+ (or 20+ if they present with a primary motor or vocal tic disorder),; suspected (based on clinical presentation) that the tics are better attributed to functional neurological symptom disorder per DSM-5-TR criteria (APA, 2022).